Newsroom - Precision NanoSystems

LATEST NEWS

Press Release

Aug 11, 2021

Precision NanoSystems sets time and place to open new Genetic Medicine GMP Biomanufacturing Centre in Vancouver, BC

Vancouver, British Columbia – August 11, 2021 - Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently under construction. Slate...

News
Events

PRESS RELEASES

Press Release

Apr 20, 2021

Precision NanoSystems Announces New Cell Therapy Reagent for Lipid Nanoparticle-based mRNA Delivery to T Cells

Cell therapy Nucleic Acid Lipid Nanoparticles mRNA

Vancouver, BC, Apr 20, 2021 - Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, today launched the GenVoy-ILM™ T Cell Kit for mRNA to enable lipid nanoparticle (LNP)-based ex vivo gene transfer. ...
Read More
Press Release

Feb 02, 2021

Precision NanoSystems Receives Contribution from the Government of Canada to Build RNA Medicine Biomanufacturing Centre

Precision NanoSystems, Inc. (PNI), a global leader in technologies and solutions for development of genetic medicines, announced today that it has received a contribution of CAD $25.1 million through the Strategic Innovation Fund (SIF). This contribution will support a CAD $50.2-...
Read More
Press Release

Oct 22, 2020

Canada’s Prime Minister, Justin Trudeau, Announced Today Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19

Precision Nanosystems, Inc., a global leader in technologies and solutions in genetic medicine, announced today that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and Economic Development’s (ISED) ...
Read More
Press Release

Jul 07, 2020

eTheRNA Immunotherapies Selects Precision NanoSystems’ NxGen™ Technology for GMP Manufacturing

eTheRNA Immunotherapies NV (eTheRNA) and Precision NanoSystems Inc. (PNI) have signed a license and supply agreement for the development and manufacture of immunotherapies by eTheRNA using its proprietary mRNA TriMix platform. PNI’s Clinical Solutions team supported eTheRNA...
Read More
Press Release

Jun 17, 2020

Sirnaomics and Precision NanoSystems Have Formed a Partnership Developing and Manufacturing Novel RNAi drug Candidates Using Precision NanoSystems’ NxGen™ Platform

Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product. This strategic joint effort includes the execution of a NanoAssemblr^&re...
Read More
Press Release

May 20, 2020

CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine

mRNA Vaccines

CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology. Precision NanoSystems will lead RNA vaccine formulation development. CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials

Read More

IN THE NEWS

News Article

Mar 16, 2020

NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins

Vaccines mRNA

The NIH and Moderna have begun phase 1 clinical trials for a vaccine to protect against COVID-19. The vaccine, called mRNA-1273, is an advanced mRNA vaccine that utilizes genetic material to immunize patients. Moderna and the NIH were able to bring mRNA-1273 to clinical trials wi...
Read More
News Article

Jul 30, 2018

Simplifying Nanomedicine Manufacturing for the Masses - BioWorld

Precision Nanosystems' Nanoassemblr technology uses microfluid continuous flow to control variables in the assembly of the nanoparticles. The company has three machines available that can scale depending on which stage of discovery a compound is in...
Read More
News Article

Apr 20, 2018

In Full Boom -Two Vancouver-based companies are creating industry leading research tools and technology and helping B.C. stake its claim as a world-class burgeoning biotech hub.

Two Vancouver-based companies are creating industry leading research tools and technology and helping B.C. stake its claim as a world-class burgeoning biotech hub. Precision NanoSystems Inc. (PNI) and Stemcell Technologies Inc. are just two of a gr...
Read More
News Article

Dec 20, 2017

Precision NanoSystems Named as One of British Columbia’s Fastest Growing Companies | Business Wire

Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journalBusiness in Vancouver&nbs...
Read More
News Article

Nov 23, 2017

Precision NanoSystems to Host Nanomedicines Roundtable | Nanotechnology Now

Join Precision NanoSystems for a roundtable discussion on nanomedicines as part of the 3rd International Electronic Conference on Medicinal Chemistry. Organised by Pharmaceuticals journal, this free online conference runs until November 30th, and d...
Read More
News Article

Oct 20, 2017

Nanomedicines - Exploring the Past, Present and Future

The commercial availability of microfluidic platforms aimed specifically at drug formulation is helping to lower the barriers to nanomedicine research. Implementation of this technology eliminates the need for in-house microfluidics expertise and e...
Read More